bioAffinity Technologies (BIAF) Other financing activities (2021 - 2026)
bioAffinity Technologies (BIAF) reported Other financing activities of $14340.0 for Q1 2026, down 95.61% year-over-year from $326616.0 in Q1 2025, and up 105.56% quarter-over-quarter from -$258057.0 in Q4 2025.
bioAffinity Technologies (BIAF) Other financing activities (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has 6 years of Other financing activities data on file, last reported at $14340.0 in Q1 2026.
- Other financing activities for Q1 2026 came in at $14340.0, down 95.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $35022.0 (down 97.32% YoY), and the FY2025 annual result was $347298.0, down 72.48% from the prior year.
- Other financing activities rose to $14340.0 in Q1 2026 per BIAF's latest filing, from -$258057.0 in the prior quarter.
- Over five years, Other financing activities peaked at $506304.0 in Q4 2024 and troughed at -$258057.0 in Q4 2025.
- A 5-year average of $142824.1 and a median of $170255.0 in 2023 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2023 and 2025: Other financing activities soared 538.02% in 2023, then slumped 150.97% in 2025.
- A 5-year view of Other financing activities shows it stood at -$156094.0 in 2022, then jumped by 250.24% to $234510.0 in 2023, then soared by 115.9% to $506304.0 in 2024, then tumbled by 150.97% to -$258057.0 in 2025, then soared by 105.56% to $14340.0 in 2026.
- Business Quant data shows BIAF's Other financing activities at $14340.0 in Q1 2026, -$258057.0 in Q4 2025, and $67132.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | bioAffinity Technologies | 2.08 Mn | -1.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14,340.00 |
| Mar 31, 2026 | 14,340.00 |
| Dec 31, 2025 | -258,057.00 |
| Dec 31, 2025 | -258,057.00 |
| Sep 30, 2025 | 67,132.00 |
| Sep 30, 2025 | 67,132.00 |
| Jun 30, 2025 | 211,607.00 |
| Jun 30, 2025 | 211,607.00 |
| Mar 31, 2025 | 326,616.00 |
| Mar 31, 2025 | 326,616.00 |
| Dec 31, 2024 | 506,304.00 |
| Dec 31, 2024 | 506,304.00 |
| Sep 30, 2024 | 185,687.00 |
| Sep 30, 2024 | 185,687.00 |
| Jun 30, 2024 | 286,195.00 |
| Jun 30, 2024 | 286,195.00 |
| Mar 31, 2024 | 283,712.00 |
| Mar 31, 2024 | 283,712.00 |
| Dec 31, 2023 | 234,510.00 |
| Dec 31, 2023 | 234,510.00 |